Cutaneous side effects of EGFR inhibitors - appearance and management

被引：24

作者：

Wollenberg, A. ^{[1
]}

Kroth, J. ^{[1
]}

Hauschild, A. ^{[2
]}

Dirschka, T. ^{[3
]}

机构：

[1] Univ Munich, Klin & Poliklin Dermatol & Allergol, D-80337 Munich, Germany

[2] Univ Klinikum Schleswig Holstein, Klin Dermatol & Allergol, Kiel, Germany

[3] Hautarztpraxis Wuppertal, Wuppertal, Germany

来源：

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2010年 / 135卷 / 04期

关键词：

EGFR-inhibitor; Cetuximab; acneiform exanthema; radiotherapy; management; GROWTH-FACTOR RECEPTOR; CETUXIMAB; PATHOGENESIS; IRINOTECAN; ERUPTIONS; LESIONS; TRIAL;

D O I：

10.1055/s-0029-1244831

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：149 / 154

页数：6

共 24 条

[1]

Bierhoff E, 2006, PATHOLOGE, V27, P53, DOI 10.1007/s00292-005-0803-0

[2] Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J].

Bonner, JA ;

Harari, PM ;

Giralt, J ;

Azarnia, N ;

Shin, DM ;

Cohen, RB ;

Jones, CU ;

Sur, R ;

Raben, D ;

Jassem, J ;

Ove, R ;

Kies, MS ;

Baselga, J ;

Youssoufian, H ;

Amellal, N ;

Rowinsky, EK ;

Ang, KK .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :567-578

[3] Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer [J].

Cunningham, D ;

Humblet, Y ;

Siena, S ;

Khayat, D ;

Bleiberg, H ;

Santoro, A ;

Bets, D ;

Mueser, M ;

Harstrick, A ;

Verslype, C ;

Chau, I ;

Van Cutsem, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (04) :337-345

[4]

Gutzmer R, 2006, HAUTARZT, V57, P509, DOI 10.1007/s00105-005-1033-3

[5] Cutaneous side effects of epidermal growth factor receptor inhibitors: Clinical presentation, pathogenesis, and management [J].

Hu, Jenny C. ;

Sadeghi, Parrish ;

Pinter-Brown, Lauren C. ;

Yashar, Sharona ;

Chin, Melvin W. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) :317-326

[6]

KATZER K, 2009, EUR J DERMATOL

[7]

Klein E, 2006, ALLERGO J, V15, P559

[8] EGF, TGF-α, and EGF-R in human colorectal adenocarcinoma [J].

Messa, C ;

Russo, F ;

Caruso, MG ;

Di Leo, A .

ACTA ONCOLOGICA, 1998, 37 (03) :285-289

[9] Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group [J].

Moore, Malcolm J. ;

Goldstein, David ;

Hamm, John ;

Figer, Arie ;

Hecht, Joel R. ;

Gallinger, Steven ;

Au, Heather J. ;

Murawa, Pawel ;

Walde, David ;

Wolff, Robert A. ;

Campos, Daniel ;

Lim, Robert ;

Ding, Keyue ;

Clark, Gary ;

Voskoglou-Nomikos, Theodora ;

Ptasynski, Mieke ;

Parulekar, Wendy .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (15) :1960-1966

[10] Cetuximab in the treatment of metastatic colorectal cancer [J].

Moosmann, Nicolas ;

Heinemann, Volker .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (02) :243-256

← 1 2 3 →